InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Allison Dorval, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 8 open-market SEC Form 4 transactions: 0 purchases worth $0 and 8 sales worth $230K, reported from Nov 29, 22 to Jun 12, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 26 | PBYIPUMA BIOTECHNOLOGY, INC. | SELL | 11.6K | $7.20 | $84K |
| Jun 13, 25 | PBYIPUMA BIOTECHNOLOGY, INC. | SELL | 11.6K | $3.40 | $39K |
| Apr 2, 25 | VERVVerve Therapeutics, Inc. | SELL | 3.4K | $4.15 | $14K |
| Dec 2, 24 | VERVVerve Therapeutics, Inc. | SELL | 555 | $5.64 | $3K |
| Jun 13, 24 | PBYIPUMA BIOTECHNOLOGY, INC. | SELL | 11.0K | $3.37 | $37K |
| Nov 29, 23 | VERVVerve Therapeutics, Inc. | SELL | 554 | $11.45 | $6K |
| Jun 13, 23 | PBYIPUMA BIOTECHNOLOGY, INC. | SELL | 10.0K | $3.45 | $35K |
| Nov 29, 22 | VERVVerve Therapeutics, Inc. | SELL | 554 | $22.10 | $12K |